Navigation Links
Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
Date:12/6/2012

ooms costs coming in over $60 per minute, it is clear that advances that reduce a patient's time in the OR are needed. A technology like ACI has the potential to accelerate the procedure for breast cancer surgery and reduce the number of times a patient is required to return to surgery to remove additional lymph nodes."

ACI utilizes the increased activity of enzymes called proteases that occur in tumors and metastases. The fluorescent peptide changes color in the presence of pathological protease activity, thereby marking the cancerous tissue. When used in conjunction with a fluorescence imaging camera system during surgery, a color-coded image showing cancerous tissue is superimposed onto the normal surgical view, providing the surgeon a map of the cancer location. 

In preclinical studies ACI has demonstrated high in vivo diagnostic sensitivity and specificity for detecting multiple rodent breast cancer metastases in lymph nodes and in ex vivo studies with human breast cancer patient tissue. By enabling real-time visualization of lymph node metastases and, potentially the primary tumor, in breast cancer, ACI has the potential to significantly improve surgical staging and decrease cancer-positive margins, the presence of which leads to reoperations.

About Avelas Biosciences

Avelas Biosciences is focused on developing fluorescent technologies that advance a new standard-of-care for cancer surgery. Its lead technology is the Avelas Cancer Illuminator™ (ACI), founded on technology from Nobel Prize winner Roger Tsien, Ph.D. The privately held company is funded by Avalon Ventures.


'/>"/>
SOURCE Avelas Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Massachusetts , June 1, 2015 ... announces that it will be participating in the Jefferies ... NY on Tuesday, June 2, 2015. ... a question and answer session at 10:00 a.m. ET ... will be available on the Presentations and Webcasts section ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "2015 Strategies in the UK Flow ... This report presents a comprehensive analysis of ... Major issues pertaining to the French flow cytometry ... social and technological trends with significant market impact ...
(Date:6/1/2015)... June 1, 2015 Hutchison ... that AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ... ongoing Phase Ib clinical trial of HMP,s c-Met ... AZD9291 in non-small cell lung cancer ("NSCLC"). ... epidermal growth factor receptor (EGFR). Preliminary data on ...
(Date:5/31/2015)... (PRWEB) May 31, 2015 The most ... Society of Clinical Oncology (ASCO) Annual Meeting – “The ... Lecture” – prominently featured presentations by immunotherapy experts and ... , James Patrick Allison, PhD, chairman of the Department ... Cancer Center and SITC committee member, received the Science ...
Breaking Biology Technology:Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3SITC Reports on Immunotherapy Insights and Data Featured at ASCO Plenary Session 2
... April 28 PharmAthene, Inc. (NYSE Amex: PIP ... threats, today announced the appointment of Mitchel Sayare , Ph.D. ... members. , , ... Dr. Sayare most recently served as Chairman and Chief Executive Officer ...
... ... and Recognition of Science and Technology), a not-for-profit organization founded by inventor Dean Kamen ... Supplier of the FIRST Robotics Competition (FRC®). , ... (PRWEB) April 28, 2010 -- Haydon Kerk Motion Solutions, ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... Tuesday, May 4, 2010 at 10:40 a.m. ET / ... chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. , ... The presentation will be webcast live through the ...
Cached Biology Technology:PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 2PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 2Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 4Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference 2
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... an ongoing effort to mirror the ability of biological ... scientists from the McGowan Institute for Regenerative Medicine have ... both biological and chemical toxins. They described the findings ... biological principles to create materials that can do many ...
... University of Florida engineering researchers have found they can ... say opens the door to a wave of new technologies ... about the research appears in this week,s advance online edition ... Ben Koopman and Brij Moudgil say they used lasers not ...
... from the Robertson Foundation to create a state-of-the-art Translational ... cell therapy research and treatment programs for children and ... suffered at birth. In making the announcement, Victor J. ... Chief Executive Officer for Duke University Health System, said ...
Cached Biology News:Multifunctional polymer neutralizes both biological and chemical weapons 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 3Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 2Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 3